The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Diamond Capital Company, startups are often financed by BioAdvance. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, Versant Ventures, TPG. In the next rounds fund is usually obtained by Visa, Versant Ventures, Pfizer Venture Investments.
Among the most popular portfolio startups of the fund, we may highlight Ecrio, Five Prime Therapeutics. The fund has no exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Operating Systems, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Diamond Capital Company performs on 38 percentage points more the average number of lead investments. The high activity for fund was in 2005. The higher amount of exits for fund were in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| BoomTown | Charleston, South Carolina, United States |
| Broadleaf | Japan, Tokyo |
| Centro Innovo Usach | Chile, Region Metropolitana, Santiago |
| eFounders | France, Ile-de-France, Paris |
| First IsraTech Fund | - |
| Gingerace Capital Partners | Dubai, United Arab Emirates |
| Hui Capital | - |
| KBI Biopharma | Durham, North Carolina, United States |
| KdT Ventures | Austin, Texas, United States |
| Kick-Start Funds | - |
| Kuka Home | China, Hangzhou, Zhejiang |
| LC Securities | - |
| Low Carbon Innovation Fund | Norfolk, Norwich, United Kingdom |
| Merapar | Netherlands, Noord-Brabant, North Brabant |
| RadNet | California, Los Angeles, United States |
| Rice Investment Group | Carnegie, Pennsylvania, United States |
| SilverStream Capital | California, San Diego, United States |
| Stairway Capital | - |
| Venture Financial Management | Reston, United States, Virginia |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ecrio | $3M | 02 Aug 2005 | Cupertino, California, United States | ||
Acuity Pharmaceuticals | $15M | 07 Oct 2004 | Philadelphia, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ecrio | $3M | 02 Aug 2005 | Cupertino, California, United States | ||
Acuity Pharmaceuticals | $15M | 07 Oct 2004 | Philadelphia, Pennsylvania, United States |
